Hear Immutep CEO Marc Voigt talk about the important and decisive period aheadSpeaking at the recent JP Morgan Healthcare Conference 2020.
Immutep Limited’s Chief Scientist and CEO, Marc give their insights into the very important and decisive period ahead for the Company, especially as it prepares to report the first clinical data from its late-stage AIPAC study in metastatic breast cancer:
https://youtu.be/xG7APbULFww
Ann: Immutep to present TACTI-002 data at German Cancer Congress, page-30
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $1.317M | 3.935M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73996 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 836970 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |